Welcome!

News Feed Item

Injectable Drug Delivery - Advances in Drug Delivery, Injection Devices and Technology (Conference, London)

 

DUBLIN, Mar. 20, 2014 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/sq2qm5/injectable_drug) has announced the addition of the "Injectable Drug Delivery - Advances in Drug Delivery, Injection Devices and Technology (Conference, London)" conference to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The Injectable Drug Delivery Conference will be held on the 26th & 27th March 2014 at Le Meridien Hotel, Piccadilly, London

KEY TOPICS TO INCLUDE:
- Market trends
- Human factors and useability
- Fluid dynamics - modelling the realities of injection performance
- Delivery of high viscosity drugs
- Case study presentation on devices in development
- Latest self injection trends
- Development of a parenteral device
- Delivery of high volumes
- Compliance modelling and parenteral drug delivery
- The insulet drug delivery system

DATES:

26 & 27 March 2014

TIMES:

Day One: 26 March 2013
Start times: 9.30 Finish 17.45

Drinks Reception Followed by Dinner 19.30

Day Two: 27 March 2013
Start times: 9.00 Finish 16.15

VENUE FOR CONFERENCE AND DINNER:

Le Meridien Hotel, Piccadilly, London

NOTE: Please note that there is a Pre-conference seminar on 25th March on 'Prefilled Syringes - Advances in Manufacture' and also a Post Conference Workshop on 28th March on 'Human Factors and Usability Engineering in the development of drug delivery products'.

Events may be cancelled due to commercial or organisational reasons. In this case Research and Markets will refund all registration fees which have already been paid. Research and Markets will not refund any charges arising from the participant having to cancel or re-book transportation or accommodation which he or she has arranged

Key Topics Covered:

INJECTABLE DRUG DELIVERY DAY ONE - 26 March 2013

09.30 - Chairman's Welcome and Introduction
Dr Gregory Berman,
Head of Innovation and Technology Management Group, Sagentia, UK

09.40 - Key Note Address: Market Trends

- High concentration formulations

- Larger doses, less frequent injections
Mathias Romacker, Drug Delivery Devices and Business Development, Amgen, USA

10.20 - Human Factors and Useability

- Ethonographic research on atuoinjector use for chronic conditions

- Relationship between a disease and its therapy - emotional and functional levels

- How this affects device selection
Mathew Young, CEO, Oval Medical Technologies Ltd, UK

11.00 - Discussion followed by Coffee

11.30 - Fluid Dynamics - Modelling the Realities of Injection Performance

- Mathematical modelling enables the opportunities and challenges of a range of device types to be explored early

- The implications of such characteristics as viscosity, dose volume and injection frequency are inseparable from the choice of delivery device

- Unfortunately, early consideration of the delivery device does not always take place. Opportunities can thus be lost and problems created which are costly and difficult to solve later

- Mathematical modelling techniques, applied properly, improve understanding of the issues concerned and enable better and earlier decisions to be taken

- Better informed decisions and better appreciations of the design options in turn support device designs which are better for the end user

- Early understanding of device issues supports and enables robust designs and capable manufacture

- Early understanding can shorten development timescales, in turn making earlier approval and earlier revenues possible
Andy Fry, Founder, Team Consulting, UK

12.10 - Delivery of High Viscosity Drugs

- Device formats

- Overcoming the challenges
Speaker, (invited)

12.50 - Discussion followed by Lunch

14.10 - Mixing Technologies for Reconstitution Devices

- Market Needs - Industry drivers and demands for these types of devices

- Latest mixing technologies

- Comparison of Lyophilised and Spray drying technologies

- Technical challenges with these types of devices
Tom Bailey, Managing Director, 3PInnovation, UK

14.50 - Device Case Study
Ian Anderson, Innovation Director, Bespak UK (invited)

15.30 - Discussion followed by Tea

16.10 - Latest Self Injection Trends

- General market trends

- Trends for biologics

- Trends for generics

- Pre-configured devices

- Future outlook
Mats Persson, Managing Director, SHL Group, Sweden

16.50 - Innovation in Primary Container Materials

- Trends for user requirements intended for self injection

- Material technology options and selection criteria

- Integration of Quality by Design for components

- Platform approach for lifecycle management
Tibor Hlobik, West Pharmaceutical Services

17.30 - Discussion

17.45 - End of Day One

19.30 - Drinks Reception Followed by Dinner at Le Meridien Hotel, London

INJECTABLE DRUG DELIVERY DAY TWO - 27 March 2013

09.00 - Review of Day One
Dr Gregory Berman,
Head of Innovation and Technology Management Group, Sagentia, UK

09.10 - What Does Pharma Want From its Drug Delivery Suppliers
Nick Bowman, Senior Director, Head of Devices COE, Pfizer, UK

09.50 - Pump Technology Case Study
Jonathan Rigby, President & CEO, SteadyMed Therapeutics Inc, USA, (invited)

10.30 - Discussion followed by Coffee

11.10 - Compliance Monitoring and Parenteral Drug Delivery

- Why is the industry suddenly talking about compliance and adherence monitoring (clinical trials and commercial applications)

- Advances in wireless communications enabling intelligent compliance monitoring

- The widespread availability of smart devices and their use in compliance monitoring, adherence and patient education

- Use of smartphone / smart devices apps for providing real-time information display and the potential for two way communications with the patient

- Regulatory issues associated with connected health systems and smartphone apps

- Using the cloud to store and disseminate data securely
Mark Tuckwell, Senior Consultant, Connected Health Systems,
Sagentia, UK

11.50 - Wireless Communication and Electronics for Compliance Monitoring

- Patient therapy compliance continues to be one of the biggest challenges in health systems

- 50% of all patients do not complete required treatment

- Reasons for the high rate of non-compliance

- Opportunities for medical manufacturers to offer innovative solutions

- Electronic compliance aids open interesting possibilities to remind, monitor and track patients' behavior, as well as to share vital therapy information with healthcare providers

- Key technologies that facilitate compliance, ranging from low-cost disposable electronics for dose counts and logs to a complete cloud-based system for monitoring compliance
Lior Shtram, Director, Design & Engineering, Flextronics Medical, Israel

12.30 - Discussion followed by Lunch

14.00 - Update on Regulations and Standards
Lee Leichter, President P/L Medical, USA

14.40 - The Insulet Drug Delivery System

Consists of two components
- Drug Delivery Pod
- Drug Delivery Manager

A Programmable, body worn, disposable, subcutaneous infusion pump

- Delivers up to 2ml of drug product over a three day period
- Delivery rate from 0.5 to 300 µl/hr
- Automated catheter insertion
- Waterproof (IPX8 25 feet for up to 60 minutes)

Provides the HCP and user maximum control, versatility, comfort and safety, while overcoming the numerous drawbacks of conventional infusion pump systems
Kevin Schmid, Vice President, Business Development & Advanced Technology Insulet Corporation, USA

15.20 - The Rise of the Bolus Injector

The changing needs of patients and new drugs are driving the growth of a new class of injection device: the large volume' or bolus' injector. This presentation will report the findings of a new research project run in collaboration with the Judge Business School, covering:

- The changing needs of patients and new drugs

- Could autoinjectors and infusion pumps meet the needs?

- Bolus injectors: a new class of injection device

- Example devices

- What to expect from the draft standard ISO 11608-6' on bolus injectors.
Tom Oakley, Director of Drug Delivery Device Development, Springboard, UK

16.00 - Discussion and Chairman's Closing Remarks

16.15 - End of Conference and Tea


For more information visit http://www.researchandmarkets.com/research/sq2qm5/injectable_drug



Media Contact: Laura Wood , +353-1-481-1716, [email protected]

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Digital transformation is about embracing digital technologies into a company's culture to better connect with its customers, automate processes, create better tools, enter new markets, etc. Such a transformation requires continuous orchestration across teams and an environment based on open collaboration and daily experiments. In his session at 21st Cloud Expo, Alex Casalboni, Technical (Cloud) Evangelist at Cloud Academy, explored and discussed the most urgent unsolved challenges to achieve f...
In his Opening Keynote at 21st Cloud Expo, John Considine, General Manager of IBM Cloud Infrastructure, led attendees through the exciting evolution of the cloud. He looked at this major disruption from the perspective of technology, business models, and what this means for enterprises of all sizes. John Considine is General Manager of Cloud Infrastructure Services at IBM. In that role he is responsible for leading IBM’s public cloud infrastructure including strategy, development, and offering m...
There is a huge demand for responsive, real-time mobile and web experiences, but current architectural patterns do not easily accommodate applications that respond to events in real time. Common solutions using message queues or HTTP long-polling quickly lead to resiliency, scalability and development velocity challenges. In his session at 21st Cloud Expo, Ryland Degnan, a Senior Software Engineer on the Netflix Edge Platform team, will discuss how by leveraging a reactive stream-based protocol,...
"I focus on what we are calling CAST Highlight, which is our SaaS application portfolio analysis tool. It is an extremely lightweight tool that can integrate with pretty much any build process right now," explained Andrew Siegmund, Application Migration Specialist for CAST, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
SYS-CON Events announced today that Evatronix will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Evatronix SA offers comprehensive solutions in the design and implementation of electronic systems, in CAD / CAM deployment, and also is a designer and manufacturer of advanced 3D scanners for professional applications.
SYS-CON Events announced today that Synametrics Technologies will exhibit at SYS-CON's 22nd International Cloud Expo®, which will take place on June 5-7, 2018, at the Javits Center in New York, NY. Synametrics Technologies is a privately held company based in Plainsboro, New Jersey that has been providing solutions for the developer community since 1997. Based on the success of its initial product offerings such as WinSQL, Xeams, SynaMan and Syncrify, Synametrics continues to create and hone inn...
As many know, the first generation of Cloud Management Platform (CMP) solutions were designed for managing virtual infrastructure (IaaS) and traditional applications. But that's no longer enough to satisfy evolving and complex business requirements. In his session at 21st Cloud Expo, Scott Davis, Embotics CTO, explored how next-generation CMPs ensure organizations can manage cloud-native and microservice-based application architectures, while also facilitating agile DevOps methodology. He expla...
To get the most out of their data, successful companies are not focusing on queries and data lakes, they are actively integrating analytics into their operations with a data-first application development approach. Real-time adjustments to improve revenues, reduce costs, or mitigate risk rely on applications that minimize latency on a variety of data sources. In his session at @BigDataExpo, Jack Norris, Senior Vice President, Data and Applications at MapR Technologies, reviewed best practices to ...
"Evatronix provides design services to companies that need to integrate the IoT technology in their products but they don't necessarily have the expertise, knowledge and design team to do so," explained Adam Morawiec, VP of Business Development at Evatronix, in this SYS-CON.tv interview at @ThingsExpo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
DevOps promotes continuous improvement through a culture of collaboration. But in real terms, how do you: Integrate activities across diverse teams and services? Make objective decisions with system-wide visibility? Use feedback loops to enable learning and improvement? With technology insights and real-world examples, in his general session at @DevOpsSummit, at 21st Cloud Expo, Andi Mann, Chief Technology Advocate at Splunk, explored how leading organizations use data-driven DevOps to close th...
Digital Transformation (DX) is not a "one-size-fits all" strategy. Each organization needs to develop its own unique, long-term DX plan. It must do so by realizing that we now live in a data-driven age, and that technologies such as Cloud Computing, Big Data, the IoT, Cognitive Computing, and Blockchain are only tools. In her general session at 21st Cloud Expo, Rebecca Wanta explained how the strategy must focus on DX and include a commitment from top management to create great IT jobs, monitor ...
"WineSOFT is a software company making proxy server software, which is widely used in the telecommunication industry or the content delivery networks or e-commerce," explained Jonathan Ahn, COO of WineSOFT, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
No hype cycles or predictions of a gazillion things here. IoT is here. You get it. You know your business and have great ideas for a business transformation strategy. What comes next? Time to make it happen. In his session at @ThingsExpo, Jay Mason, an Associate Partner of Analytics, IoT & Cybersecurity at M&S Consulting, presented a step-by-step plan to develop your technology implementation strategy. He also discussed the evaluation of communication standards and IoT messaging protocols, data...
Recently, WebRTC has a lot of eyes from market. The use cases of WebRTC are expanding - video chat, online education, online health care etc. Not only for human-to-human communication, but also IoT use cases such as machine to human use cases can be seen recently. One of the typical use-case is remote camera monitoring. With WebRTC, people can have interoperability and flexibility for deploying monitoring service. However, the benefit of WebRTC for IoT is not only its convenience and interopera...
In a recent survey, Sumo Logic surveyed 1,500 customers who employ cloud services such as Amazon Web Services (AWS), Microsoft Azure, and Google Cloud Platform (GCP). According to the survey, a quarter of the respondents have already deployed Docker containers and nearly as many (23 percent) are employing the AWS Lambda serverless computing framework. It’s clear: serverless is here to stay. The adoption does come with some needed changes, within both application development and operations. Tha...